Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.

@article{Silva2008DexmethylphenidateEC,
  title={Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder.},
  author={Raul R. Silva and Rafael Mu{\~n}{\'i}z and Linda K Pestreich and Matthew N. Brams and Alice R Mao and Ann C. Childress and James Wang},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2008},
  volume={47 2},
  pages={199-208}
}
OBJECTIVE This study compared once-daily dexmethylphenidate extended release (D-MPH-ER) 20 mg/day and placebo over 12 hours in children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) in a laboratory classroom setting. METHOD All of the children were stabilized for > or =2 weeks on a total dose (nearest equivalent) MPH 40 mg/day or immediate-release D-MPH 20 mg/day before screening. After a practice day, they received 6 days of D-MPH-ER 20 mg/day or placebo at home… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Similar Papers

Loading similar papers…